| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 47 | 2023 | 5073 | 2.540 |
Why?
|
| Biometry | 32 | 2019 | 559 | 2.470 |
Why?
|
| Prostatectomy | 46 | 2023 | 1956 | 2.410 |
Why?
|
| Prostatic Neoplasms | 76 | 2024 | 11341 | 2.140 |
Why?
|
| Surgical Procedures, Operative | 39 | 2021 | 1919 | 1.830 |
Why?
|
| Cystectomy | 16 | 2020 | 697 | 1.580 |
Why?
|
| Urinary Bladder Neoplasms | 23 | 2024 | 2277 | 1.440 |
Why?
|
| Checklist | 19 | 2024 | 827 | 1.400 |
Why?
|
| Regression Analysis | 30 | 2019 | 6361 | 1.340 |
Why?
|
| Prostate-Specific Antigen | 17 | 2024 | 2528 | 1.320 |
Why?
|
| Likelihood Functions | 24 | 2023 | 988 | 1.310 |
Why?
|
| Bayes Theorem | 9 | 2022 | 2325 | 1.310 |
Why?
|
| Data Interpretation, Statistical | 30 | 2022 | 2696 | 1.310 |
Why?
|
| Healthcare Disparities | 27 | 2024 | 3381 | 1.260 |
Why?
|
| General Surgery | 23 | 2021 | 1681 | 1.100 |
Why?
|
| Electronic Health Records | 27 | 2024 | 4763 | 1.080 |
Why?
|
| Hospitals | 33 | 2024 | 3929 | 1.030 |
Why?
|
| Accidental Falls | 10 | 2023 | 1054 | 0.980 |
Why?
|
| Medical Errors | 17 | 2023 | 1255 | 0.970 |
Why?
|
| Humans | 602 | 2024 | 760261 | 0.960 |
Why?
|
| Male | 385 | 2024 | 359413 | 0.930 |
Why?
|
| Quality Indicators, Health Care | 20 | 2024 | 1822 | 0.920 |
Why?
|
| Quality Improvement | 29 | 2024 | 3840 | 0.890 |
Why?
|
| Aged | 253 | 2024 | 168995 | 0.870 |
Why?
|
| United States | 165 | 2024 | 72363 | 0.830 |
Why?
|
| SEER Program | 27 | 2024 | 1532 | 0.820 |
Why?
|
| Patient Discharge | 15 | 2024 | 3475 | 0.810 |
Why?
|
| Postoperative Complications | 51 | 2022 | 15680 | 0.810 |
Why?
|
| Robotics | 16 | 2012 | 880 | 0.790 |
Why?
|
| Female | 360 | 2024 | 391011 | 0.770 |
Why?
|
| Hospital Mortality | 24 | 2023 | 5420 | 0.750 |
Why?
|
| Medicare | 41 | 2024 | 6771 | 0.740 |
Why?
|
| Clinical Competence | 23 | 2021 | 4786 | 0.740 |
Why?
|
| Operating Rooms | 15 | 2020 | 790 | 0.740 |
Why?
|
| Middle Aged | 241 | 2024 | 220175 | 0.730 |
Why?
|
| Decision Support Systems, Clinical | 10 | 2024 | 1162 | 0.720 |
Why?
|
| Algorithms | 21 | 2024 | 13967 | 0.710 |
Why?
|
| Logistic Models | 46 | 2023 | 13311 | 0.700 |
Why?
|
| Nephrectomy | 9 | 2020 | 1017 | 0.700 |
Why?
|
| Survival Analysis | 29 | 2022 | 10185 | 0.690 |
Why?
|
| Computer Simulation | 30 | 2023 | 6210 | 0.680 |
Why?
|
| Terminal Care | 12 | 2023 | 1759 | 0.670 |
Why?
|
| Patient Readmission | 18 | 2022 | 3327 | 0.670 |
Why?
|
| Prostate | 9 | 2023 | 1793 | 0.660 |
Why?
|
| Arthroplasty, Replacement, Knee | 11 | 2023 | 1367 | 0.660 |
Why?
|
| Laparoscopy | 18 | 2023 | 2155 | 0.650 |
Why?
|
| Linear Models | 26 | 2023 | 5876 | 0.650 |
Why?
|
| Binomial Distribution | 2 | 2014 | 23 | 0.640 |
Why?
|
| Medication Errors | 8 | 2023 | 783 | 0.630 |
Why?
|
| Multivariate Analysis | 30 | 2019 | 12156 | 0.600 |
Why?
|
| Health Services Accessibility | 20 | 2023 | 5396 | 0.590 |
Why?
|
| Cluster Analysis | 14 | 2022 | 2698 | 0.580 |
Why?
|
| Primary Health Care | 13 | 2024 | 4649 | 0.580 |
Why?
|
| Early Detection of Cancer | 14 | 2023 | 3215 | 0.570 |
Why?
|
| Patient Care Team | 13 | 2018 | 2510 | 0.570 |
Why?
|
| Retrospective Studies | 115 | 2024 | 80301 | 0.570 |
Why?
|
| Antibiotics, Antineoplastic | 11 | 2012 | 675 | 0.560 |
Why?
|
| Normal Distribution | 4 | 2022 | 273 | 0.560 |
Why?
|
| Hospitalization | 22 | 2024 | 10761 | 0.550 |
Why?
|
| Patient-Centered Care | 10 | 2021 | 1416 | 0.550 |
Why?
|
| Adult | 186 | 2024 | 219847 | 0.550 |
Why?
|
| Venous Thromboembolism | 4 | 2024 | 1866 | 0.550 |
Why?
|
| Mammaplasty | 12 | 2016 | 1239 | 0.540 |
Why?
|
| Neoplasms | 33 | 2023 | 22066 | 0.530 |
Why?
|
| Urology | 3 | 2017 | 424 | 0.530 |
Why?
|
| Inpatients | 14 | 2023 | 2578 | 0.530 |
Why?
|
| Proportional Hazards Models | 21 | 2021 | 12532 | 0.510 |
Why?
|
| Wounds and Injuries | 11 | 2020 | 2477 | 0.490 |
Why?
|
| Health Care Costs | 13 | 2023 | 3257 | 0.490 |
Why?
|
| Doxorubicin | 15 | 2013 | 2207 | 0.490 |
Why?
|
| Health Care Surveys | 12 | 2019 | 2434 | 0.480 |
Why?
|
| Space Flight | 3 | 2022 | 214 | 0.480 |
Why?
|
| Aged, 80 and over | 83 | 2024 | 58947 | 0.470 |
Why?
|
| Comparative Effectiveness Research | 4 | 2018 | 718 | 0.470 |
Why?
|
| Attitude of Health Personnel | 15 | 2024 | 3870 | 0.470 |
Why?
|
| Quality of Health Care | 19 | 2024 | 4361 | 0.470 |
Why?
|
| Kallikreins | 2 | 2017 | 231 | 0.460 |
Why?
|
| Emergency Treatment | 6 | 2020 | 498 | 0.460 |
Why?
|
| Length of Stay | 29 | 2024 | 6472 | 0.450 |
Why?
|
| Hypertension | 14 | 2024 | 8595 | 0.450 |
Why?
|
| Tourniquets | 3 | 2019 | 110 | 0.450 |
Why?
|
| Risk | 11 | 2017 | 9629 | 0.440 |
Why?
|
| Breast Neoplasms | 33 | 2024 | 21065 | 0.440 |
Why?
|
| Medically Uninsured | 8 | 2018 | 843 | 0.440 |
Why?
|
| Risk Assessment | 45 | 2024 | 24086 | 0.440 |
Why?
|
| Delivery, Obstetric | 6 | 2020 | 933 | 0.430 |
Why?
|
| Physicians | 13 | 2024 | 4590 | 0.430 |
Why?
|
| Longitudinal Studies | 31 | 2023 | 14482 | 0.420 |
Why?
|
| Propensity Score | 13 | 2023 | 1918 | 0.420 |
Why?
|
| Guideline Adherence | 13 | 2020 | 2283 | 0.420 |
Why?
|
| Internship and Residency | 15 | 2021 | 5867 | 0.410 |
Why?
|
| Monte Carlo Method | 8 | 2019 | 1256 | 0.410 |
Why?
|
| Hospital Costs | 7 | 2017 | 976 | 0.410 |
Why?
|
| Arthroplasty, Replacement, Hip | 6 | 2022 | 1403 | 0.410 |
Why?
|
| Treatment Outcome | 81 | 2024 | 64947 | 0.400 |
Why?
|
| Prostatic Hyperplasia | 3 | 2024 | 531 | 0.400 |
Why?
|
| Infusion Pumps | 4 | 2023 | 163 | 0.400 |
Why?
|
| Liver Transplantation | 2 | 2023 | 2317 | 0.400 |
Why?
|
| Kidney Neoplasms | 8 | 2023 | 4312 | 0.390 |
Why?
|
| Research Design | 13 | 2023 | 6181 | 0.390 |
Why?
|
| Carcinoma, Transitional Cell | 4 | 2021 | 800 | 0.390 |
Why?
|
| Survival Rate | 30 | 2021 | 12806 | 0.390 |
Why?
|
| Pain, Postoperative | 6 | 2021 | 1718 | 0.390 |
Why?
|
| Communication | 14 | 2023 | 3846 | 0.390 |
Why?
|
| Educational Measurement | 6 | 2021 | 1249 | 0.390 |
Why?
|
| Lymph Node Excision | 8 | 2019 | 1305 | 0.380 |
Why?
|
| Learning Curve | 4 | 2020 | 232 | 0.380 |
Why?
|
| Drug Prescriptions | 5 | 2024 | 1673 | 0.380 |
Why?
|
| Electronic Mail | 4 | 2023 | 207 | 0.380 |
Why?
|
| Patient Satisfaction | 10 | 2019 | 3451 | 0.370 |
Why?
|
| Military Medicine | 3 | 2017 | 187 | 0.370 |
Why?
|
| Maternal Health Services | 4 | 2022 | 455 | 0.370 |
Why?
|
| Diffusion of Innovation | 5 | 2018 | 730 | 0.370 |
Why?
|
| Kidney Transplantation | 3 | 2023 | 4215 | 0.370 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 | 2013 | 1539 | 0.360 |
Why?
|
| World Health Organization | 12 | 2020 | 1319 | 0.360 |
Why?
|
| Neoplasm Staging | 27 | 2021 | 11141 | 0.350 |
Why?
|
| Medicaid | 8 | 2023 | 2811 | 0.350 |
Why?
|
| Palliative Care | 7 | 2024 | 3607 | 0.350 |
Why?
|
| Specialties, Surgical | 4 | 2023 | 389 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 10 | 2024 | 3967 | 0.350 |
Why?
|
| Cross-Sectional Studies | 40 | 2024 | 25928 | 0.340 |
Why?
|
| Intensive Care Units | 7 | 2023 | 3737 | 0.340 |
Why?
|
| Chi-Square Distribution | 15 | 2023 | 3466 | 0.340 |
Why?
|
| Neoadjuvant Therapy | 8 | 2019 | 2811 | 0.340 |
Why?
|
| Ambulatory Surgical Procedures | 4 | 2024 | 464 | 0.340 |
Why?
|
| Patient Acceptance of Health Care | 9 | 2020 | 3159 | 0.340 |
Why?
|
| Infusions, Intravenous | 10 | 2023 | 2235 | 0.340 |
Why?
|
| Physicians, Primary Care | 4 | 2024 | 624 | 0.330 |
Why?
|
| Time Factors | 51 | 2024 | 40133 | 0.330 |
Why?
|
| Clinical Trials as Topic | 11 | 2018 | 8058 | 0.330 |
Why?
|
| Razoxane | 4 | 2012 | 43 | 0.330 |
Why?
|
| Survivors | 13 | 2023 | 2367 | 0.320 |
Why?
|
| Health Expenditures | 9 | 2023 | 2359 | 0.320 |
Why?
|
| Colorectal Neoplasms | 13 | 2023 | 6855 | 0.320 |
Why?
|
| Medical Oncology | 3 | 2019 | 2321 | 0.320 |
Why?
|
| Fee-for-Service Plans | 4 | 2017 | 705 | 0.320 |
Why?
|
| Urinary Bladder | 7 | 2023 | 1166 | 0.320 |
Why?
|
| Patient Participation | 6 | 2020 | 1437 | 0.310 |
Why?
|
| Emergencies | 6 | 2022 | 1217 | 0.310 |
Why?
|
| Analgesics, Opioid | 8 | 2024 | 3762 | 0.310 |
Why?
|
| Accidents, Occupational | 1 | 2010 | 248 | 0.310 |
Why?
|
| Electronics | 7 | 2022 | 317 | 0.310 |
Why?
|
| Mastectomy | 10 | 2020 | 1834 | 0.310 |
Why?
|
| Video Recording | 5 | 2021 | 957 | 0.300 |
Why?
|
| Trauma Centers | 6 | 2021 | 934 | 0.300 |
Why?
|
| Dementia | 4 | 2024 | 2638 | 0.300 |
Why?
|
| Muscle Neoplasms | 2 | 2019 | 133 | 0.290 |
Why?
|
| Antihypertensive Agents | 5 | 2024 | 2063 | 0.290 |
Why?
|
| Risk Factors | 65 | 2024 | 74269 | 0.290 |
Why?
|
| Advance Care Planning | 4 | 2019 | 697 | 0.290 |
Why?
|
| Mastectomy, Segmental | 5 | 2017 | 965 | 0.290 |
Why?
|
| Analysis of Variance | 14 | 2016 | 6242 | 0.290 |
Why?
|
| Intraoperative Complications | 6 | 2013 | 1186 | 0.290 |
Why?
|
| Safety Management | 7 | 2013 | 760 | 0.280 |
Why?
|
| Delivery of Health Care | 6 | 2023 | 5324 | 0.280 |
Why?
|
| Education, Medical, Graduate | 7 | 2021 | 2359 | 0.280 |
Why?
|
| Prospective Studies | 51 | 2024 | 54263 | 0.280 |
Why?
|
| Patient Protection and Affordable Care Act | 7 | 2023 | 1200 | 0.280 |
Why?
|
| Vascular Surgical Procedures | 7 | 2020 | 1469 | 0.270 |
Why?
|
| Statistics as Topic | 6 | 2014 | 2363 | 0.270 |
Why?
|
| Quality Assurance, Health Care | 8 | 2017 | 2178 | 0.270 |
Why?
|
| Androgen Antagonists | 4 | 2019 | 1439 | 0.270 |
Why?
|
| Databases, Factual | 23 | 2020 | 8018 | 0.270 |
Why?
|
| Confidence Intervals | 10 | 2014 | 2932 | 0.270 |
Why?
|
| Diabetes Complications | 5 | 2014 | 1342 | 0.270 |
Why?
|
| Hospitals, Community | 4 | 2024 | 367 | 0.270 |
Why?
|
| Maternal Mortality | 6 | 2020 | 300 | 0.260 |
Why?
|
| Nurses | 5 | 2020 | 2468 | 0.260 |
Why?
|
| Watchful Waiting | 3 | 2023 | 510 | 0.260 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 460 | 0.260 |
Why?
|
| Laser Therapy | 2 | 2023 | 1089 | 0.260 |
Why?
|
| Colectomy | 7 | 2022 | 694 | 0.260 |
Why?
|
| Oximetry | 3 | 2015 | 461 | 0.260 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2024 | 2296 | 0.250 |
Why?
|
| Clinical Trials, Phase III as Topic | 3 | 2010 | 859 | 0.250 |
Why?
|
| Perinatal Mortality | 3 | 2020 | 101 | 0.250 |
Why?
|
| Muscles | 3 | 2019 | 1581 | 0.250 |
Why?
|
| Workload | 5 | 2016 | 846 | 0.250 |
Why?
|
| Chemotherapy, Adjuvant | 9 | 2019 | 3531 | 0.250 |
Why?
|
| Poisson Distribution | 4 | 2015 | 507 | 0.240 |
Why?
|
| Cohort Studies | 33 | 2023 | 41317 | 0.240 |
Why?
|
| Appendectomy | 3 | 2019 | 431 | 0.240 |
Why?
|
| Quality of Life | 12 | 2023 | 13300 | 0.240 |
Why?
|
| Critical Care | 7 | 2023 | 2699 | 0.240 |
Why?
|
| Developing Countries | 6 | 2021 | 2880 | 0.240 |
Why?
|
| Hemorrhage | 5 | 2022 | 3604 | 0.240 |
Why?
|
| Odds Ratio | 19 | 2017 | 9712 | 0.240 |
Why?
|
| Appendicitis | 3 | 2019 | 674 | 0.240 |
Why?
|
| Cesarean Section | 6 | 2022 | 1386 | 0.230 |
Why?
|
| Transurethral Resection of Prostate | 3 | 2022 | 85 | 0.230 |
Why?
|
| Postoperative Period | 5 | 2021 | 1821 | 0.230 |
Why?
|
| Follow-Up Studies | 37 | 2021 | 39254 | 0.230 |
Why?
|
| Surgery, Computer-Assisted | 5 | 2012 | 1007 | 0.230 |
Why?
|
| Socioeconomic Factors | 21 | 2020 | 7803 | 0.230 |
Why?
|
| Hospitals, Pediatric | 5 | 2024 | 1853 | 0.230 |
Why?
|
| Patient Simulation | 2 | 2018 | 298 | 0.230 |
Why?
|
| Occupations | 2 | 2017 | 515 | 0.230 |
Why?
|
| Anthracyclines | 3 | 2012 | 283 | 0.230 |
Why?
|
| Statistics, Nonparametric | 7 | 2019 | 2852 | 0.230 |
Why?
|
| Rectal Neoplasms | 4 | 2020 | 1151 | 0.230 |
Why?
|
| Ischemia | 6 | 2013 | 1893 | 0.230 |
Why?
|
| South Carolina | 8 | 2017 | 100 | 0.230 |
Why?
|
| Erectile Dysfunction | 6 | 2017 | 452 | 0.220 |
Why?
|
| Hospice Care | 3 | 2023 | 692 | 0.220 |
Why?
|
| Health Education | 2 | 2021 | 1049 | 0.220 |
Why?
|
| Neoplasm Invasiveness | 10 | 2019 | 3618 | 0.220 |
Why?
|
| Heart Diseases | 10 | 2013 | 2809 | 0.220 |
Why?
|
| Reproducibility of Results | 19 | 2024 | 20048 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2022 | 10340 | 0.220 |
Why?
|
| Physician-Patient Relations | 6 | 2019 | 3242 | 0.220 |
Why?
|
| Benchmarking | 8 | 2018 | 1043 | 0.220 |
Why?
|
| Ethics Consultation | 1 | 2024 | 59 | 0.220 |
Why?
|
| Cardiotoxins | 2 | 2013 | 37 | 0.220 |
Why?
|
| Minority Groups | 7 | 2024 | 1199 | 0.220 |
Why?
|
| Child | 65 | 2024 | 79758 | 0.220 |
Why?
|
| Surgery Department, Hospital | 4 | 2012 | 177 | 0.220 |
Why?
|
| Ventricular Septum | 1 | 2023 | 76 | 0.220 |
Why?
|
| Artificial Limbs | 1 | 2024 | 121 | 0.210 |
Why?
|
| Extremities | 3 | 2018 | 867 | 0.210 |
Why?
|
| Attitude to Computers | 4 | 2018 | 195 | 0.210 |
Why?
|
| Patient Admission | 3 | 2024 | 1384 | 0.210 |
Why?
|
| Efficiency | 3 | 2016 | 477 | 0.210 |
Why?
|
| Decision Support Techniques | 3 | 2018 | 2002 | 0.210 |
Why?
|
| Adolescent | 60 | 2024 | 87747 | 0.210 |
Why?
|
| Erythroblasts | 1 | 2023 | 143 | 0.210 |
Why?
|
| Iodine | 3 | 2022 | 286 | 0.210 |
Why?
|
| Medical Records Systems, Computerized | 4 | 2009 | 1191 | 0.210 |
Why?
|
| Reimbursement Mechanisms | 2 | 2019 | 664 | 0.210 |
Why?
|
| Data Mining | 3 | 2013 | 553 | 0.210 |
Why?
|
| Boston | 20 | 2021 | 9282 | 0.210 |
Why?
|
| Respiratory Insufficiency | 2 | 2022 | 1228 | 0.210 |
Why?
|
| Astronauts | 2 | 2022 | 92 | 0.210 |
Why?
|
| Medical Audit | 4 | 2016 | 453 | 0.210 |
Why?
|
| First Aid | 2 | 2019 | 67 | 0.210 |
Why?
|
| Pharmaceutical Preparations | 5 | 2023 | 1093 | 0.210 |
Why?
|
| Military Personnel | 6 | 2019 | 1245 | 0.210 |
Why?
|
| Population Surveillance | 3 | 2010 | 2609 | 0.210 |
Why?
|
| Pulmonary Atresia | 1 | 2023 | 159 | 0.210 |
Why?
|
| Urethral Obstruction | 1 | 2022 | 56 | 0.200 |
Why?
|
| Surgery, Plastic | 3 | 2016 | 640 | 0.200 |
Why?
|
| Esophagectomy | 2 | 2020 | 469 | 0.200 |
Why?
|
| Medication Systems, Hospital | 3 | 2018 | 154 | 0.200 |
Why?
|
| Documentation | 4 | 2024 | 892 | 0.200 |
Why?
|
| Registries | 10 | 2023 | 8449 | 0.200 |
Why?
|
| Infant, Low Birth Weight | 2 | 2023 | 858 | 0.200 |
Why?
|
| Least-Squares Analysis | 4 | 1998 | 369 | 0.200 |
Why?
|
| Independent Living | 2 | 2024 | 568 | 0.200 |
Why?
|
| Cryotherapy | 2 | 2014 | 162 | 0.200 |
Why?
|
| Hip Fractures | 2 | 2024 | 989 | 0.200 |
Why?
|
| Urination | 3 | 2012 | 202 | 0.200 |
Why?
|
| Ambulatory Care | 5 | 2024 | 2783 | 0.200 |
Why?
|
| Probability | 12 | 2023 | 2476 | 0.200 |
Why?
|
| Perception | 3 | 2018 | 1194 | 0.200 |
Why?
|
| Telephone | 3 | 2014 | 623 | 0.200 |
Why?
|
| Age Factors | 20 | 2018 | 18415 | 0.190 |
Why?
|
| Hospital Information Systems | 2 | 2017 | 396 | 0.190 |
Why?
|
| Medical Order Entry Systems | 3 | 2013 | 522 | 0.190 |
Why?
|
| Massachusetts | 15 | 2024 | 8805 | 0.190 |
Why?
|
| Aftercare | 4 | 2023 | 918 | 0.190 |
Why?
|
| Radiotherapy, Adjuvant | 8 | 2017 | 1790 | 0.190 |
Why?
|
| Aerospace Medicine | 1 | 2022 | 95 | 0.190 |
Why?
|
| Program Evaluation | 7 | 2018 | 2494 | 0.190 |
Why?
|
| Echocardiography | 15 | 2013 | 4980 | 0.190 |
Why?
|
| Colorectal Surgery | 1 | 2023 | 122 | 0.190 |
Why?
|
| Young Adult | 35 | 2024 | 58673 | 0.190 |
Why?
|
| Behavior Therapy | 3 | 2014 | 869 | 0.190 |
Why?
|
| Comorbidity | 14 | 2018 | 10552 | 0.190 |
Why?
|
| Peer Group | 2 | 2020 | 674 | 0.180 |
Why?
|
| Biostatistics | 3 | 2015 | 164 | 0.180 |
Why?
|
| Health Records, Personal | 2 | 2012 | 126 | 0.180 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 14 | 2019 | 11708 | 0.180 |
Why?
|
| Access to Information | 1 | 2023 | 320 | 0.180 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 936 | 0.180 |
Why?
|
| Age Distribution | 10 | 2013 | 2893 | 0.180 |
Why?
|
| Sex Distribution | 9 | 2016 | 2295 | 0.180 |
Why?
|
| Preoperative Care | 5 | 2016 | 2255 | 0.180 |
Why?
|
| Hospital Administration | 2 | 2014 | 354 | 0.180 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2012 | 1094 | 0.180 |
Why?
|
| Sex Factors | 15 | 2024 | 10530 | 0.170 |
Why?
|
| Ureteral Neoplasms | 1 | 2021 | 110 | 0.170 |
Why?
|
| Preventive Health Services | 2 | 2018 | 571 | 0.170 |
Why?
|
| Opiate Substitution Treatment | 1 | 2024 | 435 | 0.170 |
Why?
|
| Nurse Midwives | 1 | 2020 | 23 | 0.170 |
Why?
|
| Psychotherapy | 2 | 2020 | 1640 | 0.170 |
Why?
|
| Mars | 1 | 2019 | 28 | 0.170 |
Why?
|
| Combined Modality Therapy | 15 | 2019 | 8551 | 0.170 |
Why?
|
| Injury Severity Score | 7 | 2020 | 1035 | 0.170 |
Why?
|
| Convalescence | 1 | 2020 | 106 | 0.170 |
Why?
|
| Delayed Diagnosis | 1 | 2024 | 463 | 0.170 |
Why?
|
| Diverticulitis | 1 | 2022 | 178 | 0.170 |
Why?
|
| Software | 8 | 2023 | 4420 | 0.170 |
Why?
|
| Pandemics | 10 | 2024 | 8621 | 0.170 |
Why?
|
| Leadership | 6 | 2021 | 1372 | 0.170 |
Why?
|
| Pulmonary Valve | 1 | 2023 | 414 | 0.170 |
Why?
|
| Urinary Incontinence | 6 | 2017 | 496 | 0.170 |
Why?
|
| Telemedicine | 3 | 2024 | 3005 | 0.170 |
Why?
|
| Heart | 8 | 2024 | 4392 | 0.170 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 281 | 0.170 |
Why?
|
| Respiratory Sounds | 8 | 2006 | 697 | 0.170 |
Why?
|
| Diabetes Mellitus | 5 | 2022 | 5884 | 0.170 |
Why?
|
| Acinetobacter Infections | 1 | 2019 | 71 | 0.170 |
Why?
|
| Troponin T | 7 | 2012 | 774 | 0.170 |
Why?
|
| Tracheostomy | 1 | 2023 | 425 | 0.160 |
Why?
|
| Thinness | 1 | 2023 | 491 | 0.160 |
Why?
|
| Sample Size | 4 | 2014 | 840 | 0.160 |
Why?
|
| Residence Characteristics | 4 | 2022 | 2058 | 0.160 |
Why?
|
| Brachytherapy | 3 | 2018 | 1240 | 0.160 |
Why?
|
| Cancer Care Facilities | 4 | 2018 | 425 | 0.160 |
Why?
|
| Veterans | 5 | 2022 | 2640 | 0.160 |
Why?
|
| Thoracic Outlet Syndrome | 1 | 2020 | 97 | 0.160 |
Why?
|
| Family Practice | 1 | 2002 | 512 | 0.160 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2010 | 2569 | 0.160 |
Why?
|
| Blood Pressure | 8 | 2021 | 8523 | 0.160 |
Why?
|
| Patient Education as Topic | 4 | 2021 | 2311 | 0.160 |
Why?
|
| Insurance Coverage | 7 | 2023 | 1939 | 0.160 |
Why?
|
| India | 7 | 2020 | 2346 | 0.160 |
Why?
|
| Prosthesis Design | 2 | 2024 | 2127 | 0.160 |
Why?
|
| Tibia | 1 | 2024 | 1065 | 0.160 |
Why?
|
| Urban Health | 2 | 2006 | 533 | 0.160 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2022 | 1199 | 0.160 |
Why?
|
| Opioid-Related Disorders | 3 | 2024 | 2135 | 0.160 |
Why?
|
| Adenocarcinoma | 8 | 2017 | 6310 | 0.160 |
Why?
|
| Child, Preschool | 36 | 2023 | 42034 | 0.160 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2023 | 1583 | 0.160 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2002 | 661 | 0.160 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2020 | 115 | 0.160 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2017 | 938 | 0.160 |
Why?
|
| Surgical Sponges | 2 | 2008 | 39 | 0.160 |
Why?
|
| Cardiovascular Diseases | 11 | 2018 | 15740 | 0.150 |
Why?
|
| Minority Health | 1 | 2019 | 80 | 0.150 |
Why?
|
| Surgical Flaps | 4 | 2010 | 1666 | 0.150 |
Why?
|
| Body Mass Index | 13 | 2022 | 12901 | 0.150 |
Why?
|
| Health Facilities | 2 | 2020 | 578 | 0.150 |
Why?
|
| Academic Medical Centers | 10 | 2023 | 2753 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 593 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 5 | 2017 | 2469 | 0.150 |
Why?
|
| Inservice Training | 3 | 2017 | 376 | 0.150 |
Why?
|
| Tetralogy of Fallot | 1 | 2023 | 631 | 0.150 |
Why?
|
| Esophageal Neoplasms | 3 | 2020 | 1651 | 0.150 |
Why?
|
| Adiposity | 4 | 2013 | 1851 | 0.150 |
Why?
|
| Incidence | 20 | 2023 | 21378 | 0.150 |
Why?
|
| Child, Hospitalized | 2 | 2017 | 182 | 0.150 |
Why?
|
| Infant, Newborn | 20 | 2023 | 26168 | 0.150 |
Why?
|
| Communications Media | 1 | 2018 | 42 | 0.150 |
Why?
|
| Liver Neoplasms | 8 | 2023 | 4317 | 0.150 |
Why?
|
| Cardiomyopathies | 5 | 2012 | 1945 | 0.150 |
Why?
|
| Patients | 2 | 2016 | 906 | 0.150 |
Why?
|
| Decision Trees | 1 | 2019 | 506 | 0.150 |
Why?
|
| Microcomputers | 1 | 2018 | 141 | 0.150 |
Why?
|
| Health Surveys | 7 | 2018 | 4061 | 0.150 |
Why?
|
| Life Expectancy | 5 | 2019 | 1249 | 0.150 |
Why?
|
| Surgical Instruments | 2 | 2012 | 385 | 0.150 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2019 | 3217 | 0.140 |
Why?
|
| Nutrition Surveys | 5 | 2024 | 1727 | 0.140 |
Why?
|
| Wound Infection | 1 | 2019 | 243 | 0.140 |
Why?
|
| Equipment Safety | 2 | 2016 | 253 | 0.140 |
Why?
|
| Psychometrics | 4 | 2020 | 3049 | 0.140 |
Why?
|
| Professional-Family Relations | 2 | 2018 | 495 | 0.140 |
Why?
|
| Fontan Procedure | 1 | 2023 | 791 | 0.140 |
Why?
|
| Travel | 1 | 2023 | 786 | 0.140 |
Why?
|
| Hospitals, Teaching | 4 | 2017 | 1166 | 0.140 |
Why?
|
| Appendiceal Neoplasms | 1 | 2019 | 155 | 0.140 |
Why?
|
| Competency-Based Education | 2 | 2010 | 218 | 0.140 |
Why?
|
| Periodontal Diseases | 2 | 2019 | 452 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2018 | 6545 | 0.140 |
Why?
|
| Physical Exertion | 1 | 2020 | 662 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 1038 | 0.140 |
Why?
|
| Lung Neoplasms | 6 | 2024 | 13249 | 0.140 |
Why?
|
| Health Care Reform | 4 | 2019 | 1245 | 0.140 |
Why?
|
| Malpractice | 8 | 2007 | 556 | 0.140 |
Why?
|
| Feedback | 2 | 2023 | 791 | 0.140 |
Why?
|
| Physicians, Family | 2 | 2009 | 349 | 0.140 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2023 | 833 | 0.140 |
Why?
|
| Clinical Clerkship | 3 | 2013 | 563 | 0.140 |
Why?
|
| Health Status Disparities | 3 | 2023 | 1819 | 0.140 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2018 | 785 | 0.140 |
Why?
|
| Hospital Units | 1 | 2017 | 142 | 0.140 |
Why?
|
| Sentinel Lymph Node Biopsy | 3 | 2010 | 727 | 0.140 |
Why?
|
| Buprenorphine | 1 | 2024 | 653 | 0.130 |
Why?
|
| Salvage Therapy | 2 | 2014 | 1266 | 0.130 |
Why?
|
| Forecasting | 3 | 2017 | 2931 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 1 | 2001 | 1375 | 0.130 |
Why?
|
| Surgicenters | 1 | 2016 | 45 | 0.130 |
Why?
|
| Medical Staff, Hospital | 2 | 2011 | 600 | 0.130 |
Why?
|
| Midwifery | 1 | 2017 | 122 | 0.130 |
Why?
|
| Health Communication | 1 | 2019 | 212 | 0.130 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2017 | 108 | 0.130 |
Why?
|
| Intestinal Obstruction | 2 | 2018 | 435 | 0.130 |
Why?
|
| Urologic Neoplasms | 2 | 2017 | 321 | 0.130 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2009 | 515 | 0.130 |
Why?
|
| National Health Insurance, United States | 1 | 2016 | 100 | 0.130 |
Why?
|
| Hypoalbuminemia | 1 | 2016 | 87 | 0.130 |
Why?
|
| Patient Compliance | 4 | 2014 | 2689 | 0.130 |
Why?
|
| Health Status Indicators | 3 | 2011 | 968 | 0.130 |
Why?
|
| Lawyers | 1 | 2016 | 38 | 0.130 |
Why?
|
| Markov Chains | 2 | 2019 | 971 | 0.130 |
Why?
|
| Health Resources | 3 | 2013 | 936 | 0.130 |
Why?
|
| Behavioral Risk Factor Surveillance System | 4 | 2019 | 208 | 0.130 |
Why?
|
| Substance-Related Disorders | 3 | 2023 | 4370 | 0.130 |
Why?
|
| Surgical Wound Infection | 5 | 2016 | 1529 | 0.130 |
Why?
|
| Nurse-Patient Relations | 1 | 2016 | 100 | 0.130 |
Why?
|
| Postoperative Care | 3 | 2021 | 1478 | 0.130 |
Why?
|
| Critical Illness | 6 | 2020 | 2709 | 0.130 |
Why?
|
| Diagnosis | 2 | 2024 | 157 | 0.130 |
Why?
|
| Lymphatic Metastasis | 6 | 2019 | 2945 | 0.130 |
Why?
|
| Wounds, Gunshot | 1 | 2021 | 581 | 0.130 |
Why?
|
| Medication Adherence | 4 | 2021 | 2163 | 0.130 |
Why?
|
| Task Performance and Analysis | 3 | 2018 | 759 | 0.130 |
Why?
|
| Predictive Value of Tests | 15 | 2023 | 15273 | 0.130 |
Why?
|
| Health Behavior | 5 | 2022 | 2621 | 0.130 |
Why?
|
| Coronary Disease | 3 | 2005 | 5993 | 0.130 |
Why?
|
| Pilot Projects | 11 | 2020 | 8553 | 0.130 |
Why?
|
| Recovery of Function | 7 | 2020 | 2982 | 0.130 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2018 | 2018 | 0.130 |
Why?
|
| Ventricular Function, Left | 9 | 2012 | 3870 | 0.130 |
Why?
|
| Personnel, Hospital | 1 | 2017 | 285 | 0.130 |
Why?
|
| Epidemiologic Methods | 4 | 2012 | 1344 | 0.130 |
Why?
|
| Sampling Studies | 4 | 2015 | 614 | 0.130 |
Why?
|
| Cross-Cultural Comparison | 1 | 1998 | 632 | 0.130 |
Why?
|
| Veterans Health | 1 | 2017 | 216 | 0.120 |
Why?
|
| National Health Programs | 1 | 1998 | 442 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 623 | 0.120 |
Why?
|
| Clinical Protocols | 2 | 2018 | 1439 | 0.120 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2016 | 195 | 0.120 |
Why?
|
| Mutagenicity Tests | 1 | 1994 | 46 | 0.120 |
Why?
|
| Carcinoma in Situ | 2 | 2012 | 796 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 2255 | 0.120 |
Why?
|
| Urothelium | 1 | 2017 | 277 | 0.120 |
Why?
|
| Population Density | 1 | 2015 | 192 | 0.120 |
Why?
|
| Oxytocics | 1 | 2015 | 65 | 0.120 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2017 | 258 | 0.120 |
Why?
|
| HIV | 1 | 2002 | 1579 | 0.120 |
Why?
|
| Controlled Clinical Trials as Topic | 2 | 2009 | 186 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2018 | 387 | 0.120 |
Why?
|
| Endpoint Determination | 1 | 2017 | 597 | 0.120 |
Why?
|
| Emergency Service, Hospital | 6 | 2021 | 7809 | 0.120 |
Why?
|
| Marital Status | 1 | 2016 | 432 | 0.120 |
Why?
|
| Ghana | 3 | 2020 | 312 | 0.120 |
Why?
|
| Heart Arrest | 3 | 2021 | 1506 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2023 | 1302 | 0.120 |
Why?
|
| Health Services Needs and Demand | 3 | 2019 | 1399 | 0.120 |
Why?
|
| Goals | 2 | 2019 | 708 | 0.120 |
Why?
|
| Office Visits | 2 | 2016 | 597 | 0.120 |
Why?
|
| Postpartum Period | 2 | 2018 | 1168 | 0.120 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 2135 | 0.120 |
Why?
|
| Unnecessary Procedures | 3 | 2017 | 413 | 0.120 |
Why?
|
| Medical Records | 4 | 2012 | 1407 | 0.120 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2017 | 333 | 0.120 |
Why?
|
| Traumatology | 1 | 2015 | 94 | 0.120 |
Why?
|
| Nursing Services | 1 | 2013 | 6 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2007 | 415 | 0.120 |
Why?
|
| Cardiovascular Agents | 4 | 2010 | 864 | 0.120 |
Why?
|
| Pneumonia | 4 | 2020 | 2138 | 0.120 |
Why?
|
| Health Status | 5 | 2018 | 4081 | 0.120 |
Why?
|
| Terminally Ill | 1 | 2016 | 240 | 0.120 |
Why?
|
| Managed Care Programs | 1 | 2019 | 939 | 0.120 |
Why?
|
| Infant Mortality | 2 | 2016 | 756 | 0.110 |
Why?
|
| Guidelines as Topic | 3 | 2017 | 1395 | 0.110 |
Why?
|
| Labor, Obstetric | 1 | 2017 | 321 | 0.110 |
Why?
|
| Insurance Benefits | 1 | 2016 | 191 | 0.110 |
Why?
|
| Biomedical Technology | 1 | 2016 | 211 | 0.110 |
Why?
|
| Disease-Free Survival | 10 | 2013 | 6830 | 0.110 |
Why?
|
| Foreign Bodies | 2 | 2008 | 397 | 0.110 |
Why?
|
| Case-Control Studies | 9 | 2024 | 22041 | 0.110 |
Why?
|
| Toxicology | 1 | 1994 | 103 | 0.110 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2016 | 576 | 0.110 |
Why?
|
| Child Health Services | 3 | 2013 | 644 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 7 | 2024 | 7468 | 0.110 |
Why?
|
| Vaginal Smears | 2 | 2021 | 495 | 0.110 |
Why?
|
| Computers | 1 | 2016 | 595 | 0.110 |
Why?
|
| Smoking | 9 | 2024 | 9070 | 0.110 |
Why?
|
| Coronary Artery Bypass | 3 | 2019 | 2273 | 0.110 |
Why?
|
| Education, Medical | 2 | 2017 | 1728 | 0.110 |
Why?
|
| Health Promotion | 3 | 2018 | 2208 | 0.110 |
Why?
|
| Colonic Neoplasms | 2 | 2024 | 2526 | 0.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2015 | 231 | 0.110 |
Why?
|
| Computational Biology | 2 | 2005 | 3504 | 0.110 |
Why?
|
| Infant | 25 | 2023 | 36030 | 0.110 |
Why?
|
| Cost Savings | 4 | 2023 | 920 | 0.110 |
Why?
|
| Problem-Based Learning | 1 | 2017 | 352 | 0.110 |
Why?
|
| Siblings | 3 | 2013 | 825 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 1998 | 787 | 0.110 |
Why?
|
| Directive Counseling | 1 | 2014 | 170 | 0.110 |
Why?
|
| Air Pollution | 6 | 1996 | 2316 | 0.110 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 2623 | 0.110 |
Why?
|
| Nursing Care | 1 | 2013 | 65 | 0.110 |
Why?
|
| Intention | 1 | 2016 | 337 | 0.110 |
Why?
|
| Certificate of Need | 1 | 2012 | 12 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 924 | 0.110 |
Why?
|
| Leg | 2 | 2009 | 1091 | 0.110 |
Why?
|
| Florida | 3 | 2018 | 427 | 0.110 |
Why?
|
| Heart Ventricles | 5 | 2024 | 3811 | 0.110 |
Why?
|
| Capacity Building | 1 | 2015 | 258 | 0.110 |
Why?
|
| Mammography | 6 | 2021 | 2452 | 0.110 |
Why?
|
| Pregnancy | 15 | 2022 | 29725 | 0.110 |
Why?
|
| Antineoplastic Agents | 11 | 2016 | 13629 | 0.110 |
Why?
|
| Spinal Fusion | 2 | 2019 | 1280 | 0.110 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 977 | 0.110 |
Why?
|
| Surgical Stomas | 1 | 2012 | 42 | 0.100 |
Why?
|
| Neoplasm Metastasis | 6 | 2023 | 4891 | 0.100 |
Why?
|
| Muscle Tonus | 1 | 2012 | 82 | 0.100 |
Why?
|
| Vocabulary, Controlled | 1 | 2013 | 167 | 0.100 |
Why?
|
| Referral and Consultation | 3 | 2023 | 3598 | 0.100 |
Why?
|
| Hospitals, Military | 3 | 2017 | 62 | 0.100 |
Why?
|
| Matched-Pair Analysis | 2 | 2003 | 284 | 0.100 |
Why?
|
| Blood Transfusion | 6 | 2017 | 1328 | 0.100 |
Why?
|
| Triage | 1 | 2019 | 982 | 0.100 |
Why?
|
| Hospital Administrators | 1 | 2012 | 57 | 0.100 |
Why?
|
| Burnout, Professional | 1 | 2021 | 703 | 0.100 |
Why?
|
| Personnel Selection | 1 | 2014 | 193 | 0.100 |
Why?
|
| Internationality | 3 | 2016 | 1005 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 1455 | 0.100 |
Why?
|
| Manikins | 1 | 2014 | 243 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2018 | 800 | 0.100 |
Why?
|
| Insurance Carriers | 1 | 2014 | 156 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 1 | 2018 | 756 | 0.100 |
Why?
|
| Ventricular Remodeling | 3 | 2023 | 1259 | 0.100 |
Why?
|
| Health Services | 1 | 2017 | 754 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2024 | 2064 | 0.100 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2018 | 1153 | 0.100 |
Why?
|
| Pneumonectomy | 2 | 2017 | 1110 | 0.100 |
Why?
|
| Hemochromatosis | 1 | 2013 | 174 | 0.100 |
Why?
|
| Caregivers | 2 | 2023 | 2222 | 0.100 |
Why?
|
| Endarterectomy, Carotid | 1 | 2017 | 560 | 0.100 |
Why?
|
| Professional Competence | 1 | 2015 | 431 | 0.100 |
Why?
|
| Depression | 3 | 2023 | 8033 | 0.100 |
Why?
|
| Internet | 2 | 2016 | 3074 | 0.100 |
Why?
|
| Heart Defects, Congenital | 3 | 2023 | 4668 | 0.100 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1935 | 0.100 |
Why?
|
| Postpartum Hemorrhage | 1 | 2015 | 265 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2024 | 36247 | 0.100 |
Why?
|
| Data Collection | 6 | 2011 | 3317 | 0.100 |
Why?
|
| Interprofessional Relations | 3 | 2015 | 989 | 0.090 |
Why?
|
| Thyroid Neoplasms | 3 | 2022 | 2332 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2017 | 9274 | 0.090 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2019 | 1523 | 0.090 |
Why?
|
| Veins | 3 | 2010 | 765 | 0.090 |
Why?
|
| Anal Canal | 1 | 2014 | 373 | 0.090 |
Why?
|
| Thromboembolism | 1 | 2018 | 1016 | 0.090 |
Why?
|
| Geographic Information Systems | 2 | 2020 | 280 | 0.090 |
Why?
|
| Oxytocin | 1 | 2015 | 401 | 0.090 |
Why?
|
| Health Care Coalitions | 1 | 2011 | 36 | 0.090 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 8551 | 0.090 |
Why?
|
| Economic Competition | 1 | 2013 | 218 | 0.090 |
Why?
|
| Patient Selection | 3 | 2020 | 4276 | 0.090 |
Why?
|
| Intraoperative Care | 3 | 2012 | 768 | 0.090 |
Why?
|
| Facial Transplantation | 1 | 2013 | 221 | 0.090 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 2940 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2024 | 4896 | 0.090 |
Why?
|
| Cause of Death | 5 | 2016 | 3723 | 0.090 |
Why?
|
| Fluorouracil | 8 | 2005 | 1630 | 0.090 |
Why?
|
| Health Services Research | 3 | 2019 | 1811 | 0.090 |
Why?
|
| Sutures | 2 | 2010 | 294 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 1405 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 5 | 2018 | 5333 | 0.090 |
Why?
|
| Surgical Mesh | 2 | 2010 | 315 | 0.090 |
Why?
|
| Self Efficacy | 2 | 2014 | 629 | 0.090 |
Why?
|
| Feasibility Studies | 6 | 2023 | 5201 | 0.090 |
Why?
|
| Polyglactin 910 | 1 | 2010 | 55 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2023 | 3530 | 0.090 |
Why?
|
| Culture | 1 | 2014 | 622 | 0.090 |
Why?
|
| Resuscitation | 1 | 2015 | 662 | 0.090 |
Why?
|
| Axilla | 2 | 2010 | 618 | 0.090 |
Why?
|
| Androgens | 1 | 2018 | 1289 | 0.090 |
Why?
|
| Mathematical Computing | 1 | 1990 | 143 | 0.090 |
Why?
|
| Physician's Role | 1 | 2017 | 920 | 0.090 |
Why?
|
| Work Schedule Tolerance | 2 | 2016 | 551 | 0.090 |
Why?
|
| Income | 6 | 2024 | 1876 | 0.090 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 103 | 0.090 |
Why?
|
| Pregnancy Outcome | 2 | 2019 | 2906 | 0.090 |
Why?
|
| Patient Access to Records | 1 | 2011 | 119 | 0.090 |
Why?
|
| Patient Identification Systems | 1 | 2010 | 75 | 0.090 |
Why?
|
| Renal Artery | 1 | 2012 | 368 | 0.090 |
Why?
|
| Heart Failure | 6 | 2020 | 11835 | 0.090 |
Why?
|
| Models, Theoretical | 3 | 2016 | 3561 | 0.090 |
Why?
|
| Cranial Irradiation | 1 | 2012 | 391 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2017 | 872 | 0.090 |
Why?
|
| Canada | 4 | 2019 | 2128 | 0.090 |
Why?
|
| Colposcopy | 1 | 2010 | 150 | 0.080 |
Why?
|
| Fluvoxamine | 2 | 1999 | 78 | 0.080 |
Why?
|
| Health Services for the Aged | 1 | 2012 | 259 | 0.080 |
Why?
|
| Breast Self-Examination | 1 | 2009 | 33 | 0.080 |
Why?
|
| New Jersey | 1 | 2010 | 291 | 0.080 |
Why?
|
| Endocrine System Diseases | 1 | 2012 | 251 | 0.080 |
Why?
|
| Patient Care | 3 | 2023 | 624 | 0.080 |
Why?
|
| Phenotype | 2 | 2024 | 16543 | 0.080 |
Why?
|
| Hospitals, Urban | 2 | 2010 | 499 | 0.080 |
Why?
|
| Ethylene Glycol | 1 | 2009 | 31 | 0.080 |
Why?
|
| Headache | 2 | 2021 | 1249 | 0.080 |
Why?
|
| Phlebotomy | 1 | 2010 | 137 | 0.080 |
Why?
|
| Narcotics | 1 | 2011 | 336 | 0.080 |
Why?
|
| Abdomen | 1 | 2015 | 1124 | 0.080 |
Why?
|
| Hospitals, General | 3 | 2023 | 795 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 4012 | 0.080 |
Why?
|
| Family | 5 | 2020 | 3189 | 0.080 |
Why?
|
| Hospital Bed Capacity | 1 | 2010 | 210 | 0.080 |
Why?
|
| Evidence-Based Medicine | 5 | 2018 | 3696 | 0.080 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 978 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2012 | 1067 | 0.080 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2012 | 801 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2005 | 2129 | 0.080 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 2009 | 102 | 0.080 |
Why?
|
| Case Management | 1 | 2011 | 273 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2010 | 214 | 0.080 |
Why?
|
| Spinal Fractures | 1 | 2015 | 698 | 0.080 |
Why?
|
| Insurance, Health | 2 | 2019 | 2500 | 0.080 |
Why?
|
| Body Water | 1 | 2010 | 335 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1500 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 546 | 0.080 |
Why?
|
| Specialization | 1 | 2013 | 779 | 0.080 |
Why?
|
| Random Allocation | 4 | 2022 | 2394 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 2414 | 0.080 |
Why?
|
| Suture Techniques | 2 | 2010 | 788 | 0.080 |
Why?
|
| Risk Adjustment | 3 | 2017 | 601 | 0.080 |
Why?
|
| Emotions | 2 | 2011 | 2730 | 0.080 |
Why?
|
| Fees, Pharmaceutical | 1 | 2008 | 66 | 0.080 |
Why?
|
| Interdisciplinary Communication | 2 | 2011 | 934 | 0.080 |
Why?
|
| Mass Screening | 7 | 2021 | 5422 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2007 | 1920 | 0.080 |
Why?
|
| Carcinoma | 2 | 2011 | 2334 | 0.080 |
Why?
|
| Myocardial Infarction | 5 | 2020 | 11891 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2012 | 732 | 0.080 |
Why?
|
| Burns | 1 | 2019 | 1865 | 0.080 |
Why?
|
| Prognosis | 13 | 2018 | 29636 | 0.080 |
Why?
|
| Prescription Drugs | 2 | 2019 | 630 | 0.080 |
Why?
|
| Hodgkin Disease | 2 | 2007 | 1381 | 0.080 |
Why?
|
| Poverty | 4 | 2023 | 2695 | 0.080 |
Why?
|
| Faculty, Medical | 3 | 2011 | 1192 | 0.080 |
Why?
|
| Device Approval | 1 | 2009 | 165 | 0.070 |
Why?
|
| Self Report | 3 | 2018 | 3707 | 0.070 |
Why?
|
| Medical Informatics Applications | 1 | 2009 | 179 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 6 | 2023 | 5507 | 0.070 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2007 | 24 | 0.070 |
Why?
|
| Tobacco Smoke Pollution | 5 | 2006 | 810 | 0.070 |
Why?
|
| Models, Biological | 5 | 2010 | 9468 | 0.070 |
Why?
|
| Pelvis | 3 | 2019 | 743 | 0.070 |
Why?
|
| Asthma | 3 | 2004 | 6167 | 0.070 |
Why?
|
| Costs and Cost Analysis | 4 | 2015 | 1679 | 0.070 |
Why?
|
| Morbidity | 5 | 2017 | 1765 | 0.070 |
Why?
|
| Consumer Health Information | 1 | 2010 | 209 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 20484 | 0.070 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2009 | 265 | 0.070 |
Why?
|
| Lymph Nodes | 3 | 2017 | 3491 | 0.070 |
Why?
|
| Arthroplasty | 1 | 2010 | 313 | 0.070 |
Why?
|
| Face | 1 | 2013 | 1017 | 0.070 |
Why?
|
| Mortality | 4 | 2024 | 2916 | 0.070 |
Why?
|
| Nursing Staff, Hospital | 1 | 2010 | 344 | 0.070 |
Why?
|
| Asia | 3 | 2015 | 618 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5248 | 0.070 |
Why?
|
| Cross Infection | 3 | 2014 | 1434 | 0.070 |
Why?
|
| Troponin I | 3 | 2008 | 634 | 0.070 |
Why?
|
| Orthopedics | 1 | 2016 | 891 | 0.070 |
Why?
|
| Testosterone | 1 | 2018 | 2469 | 0.070 |
Why?
|
| Paintings | 1 | 2008 | 103 | 0.070 |
Why?
|
| Israel | 3 | 2016 | 722 | 0.070 |
Why?
|
| Denmark | 3 | 2016 | 759 | 0.070 |
Why?
|
| Troponin | 2 | 2003 | 516 | 0.070 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2011 | 368 | 0.070 |
Why?
|
| Diagnostic Imaging | 2 | 2011 | 3526 | 0.070 |
Why?
|
| Interferon-alpha | 3 | 2002 | 919 | 0.070 |
Why?
|
| Emergency Medicine | 1 | 2016 | 1195 | 0.070 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2011 | 347 | 0.070 |
Why?
|
| Hernia, Ventral | 1 | 2010 | 214 | 0.070 |
Why?
|
| Communication Barriers | 2 | 2024 | 415 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 3 | 2021 | 1723 | 0.070 |
Why?
|
| Treatment Failure | 5 | 2015 | 2646 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2012 | 1705 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2002 | 640 | 0.070 |
Why?
|
| Observation | 1 | 2008 | 312 | 0.070 |
Why?
|
| Germany | 2 | 2018 | 875 | 0.070 |
Why?
|
| Prevalence | 7 | 2023 | 15687 | 0.070 |
Why?
|
| Blood Loss, Surgical | 4 | 2012 | 657 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 1840 | 0.070 |
Why?
|
| Didanosine | 2 | 2010 | 151 | 0.070 |
Why?
|
| Auranofin | 3 | 1999 | 16 | 0.070 |
Why?
|
| Vitamin K | 1 | 2008 | 321 | 0.070 |
Why?
|
| Catheterization, Peripheral | 1 | 2009 | 342 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2010 | 2197 | 0.070 |
Why?
|
| Cryosurgery | 1 | 2011 | 473 | 0.070 |
Why?
|
| Limb Salvage | 1 | 2008 | 466 | 0.070 |
Why?
|
| Back Pain | 1 | 2010 | 543 | 0.070 |
Why?
|
| Diet | 4 | 2013 | 8008 | 0.070 |
Why?
|
| Head | 1 | 2012 | 922 | 0.070 |
Why?
|
| Tunica Media | 1 | 2006 | 112 | 0.060 |
Why?
|
| Insurance Claim Review | 3 | 2019 | 737 | 0.060 |
Why?
|
| Accidents, Traffic | 2 | 2021 | 814 | 0.060 |
Why?
|
| Intestinal Diseases | 1 | 2010 | 507 | 0.060 |
Why?
|
| Job Satisfaction | 1 | 2009 | 539 | 0.060 |
Why?
|
| Bioprosthesis | 1 | 2010 | 599 | 0.060 |
Why?
|
| New York | 6 | 2020 | 874 | 0.060 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 498 | 0.060 |
Why?
|
| Nurse Practitioners | 2 | 2024 | 268 | 0.060 |
Why?
|
| Emergency Medical Services | 3 | 2012 | 1927 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 2 | 2019 | 450 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 752 | 0.060 |
Why?
|
| Comprehension | 1 | 2010 | 613 | 0.060 |
Why?
|
| Teaching | 1 | 2013 | 1167 | 0.060 |
Why?
|
| Energy Intake | 1 | 2013 | 2128 | 0.060 |
Why?
|
| Severity of Illness Index | 6 | 2020 | 15827 | 0.060 |
Why?
|
| Stents | 1 | 2017 | 3303 | 0.060 |
Why?
|
| Disease | 1 | 2010 | 671 | 0.060 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 2056 | 0.060 |
Why?
|
| Sensitivity and Specificity | 9 | 2015 | 14656 | 0.060 |
Why?
|
| Cognition | 2 | 2023 | 6948 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 1859 | 0.060 |
Why?
|
| Angioplasty | 1 | 2007 | 360 | 0.060 |
Why?
|
| Rural Health Services | 2 | 2019 | 381 | 0.060 |
Why?
|
| Workflow | 3 | 2016 | 851 | 0.060 |
Why?
|
| Melanoma | 2 | 2019 | 5695 | 0.060 |
Why?
|
| Arsenic | 2 | 1998 | 357 | 0.060 |
Why?
|
| Enalapril | 2 | 2005 | 313 | 0.060 |
Why?
|
| Demography | 3 | 2018 | 1650 | 0.060 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2024 | 81 | 0.060 |
Why?
|
| Heart Valve Diseases | 2 | 2010 | 1047 | 0.060 |
Why?
|
| Workplace | 1 | 2011 | 858 | 0.060 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2008 | 517 | 0.060 |
Why?
|
| Body Composition | 2 | 2013 | 2418 | 0.060 |
Why?
|
| Rural Health | 1 | 2006 | 299 | 0.060 |
Why?
|
| Schizophrenia | 2 | 2011 | 6915 | 0.060 |
Why?
|
| Hospitals, University | 4 | 2009 | 568 | 0.060 |
Why?
|
| Streptozocin | 3 | 2007 | 193 | 0.060 |
Why?
|
| Zidovudine | 2 | 2010 | 624 | 0.060 |
Why?
|
| Water Pollutants, Chemical | 2 | 1998 | 354 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2017 | 9283 | 0.060 |
Why?
|
| Caffeine | 1 | 2008 | 701 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2007 | 560 | 0.060 |
Why?
|
| Chest Pain | 2 | 2021 | 1106 | 0.060 |
Why?
|
| Hemoglobins | 3 | 2011 | 1521 | 0.060 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 495 | 0.060 |
Why?
|
| Amputees | 1 | 2024 | 84 | 0.060 |
Why?
|
| Informed Consent | 1 | 2010 | 1007 | 0.060 |
Why?
|
| Ubiquinone | 1 | 2005 | 183 | 0.060 |
Why?
|
| Tunica Intima | 1 | 2006 | 459 | 0.060 |
Why?
|
| Tricuspid Valve | 1 | 2006 | 409 | 0.060 |
Why?
|
| Carcinoid Tumor | 1 | 2005 | 228 | 0.060 |
Why?
|
| Thoracic Surgery | 1 | 2010 | 722 | 0.060 |
Why?
|
| Control Groups | 1 | 2023 | 105 | 0.060 |
Why?
|
| Physicians, Women | 1 | 2009 | 492 | 0.060 |
Why?
|
| Mathematics | 2 | 1995 | 708 | 0.060 |
Why?
|
| Medicare Part D | 1 | 2008 | 354 | 0.060 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2024 | 75 | 0.050 |
Why?
|
| Risk Management | 1 | 2007 | 558 | 0.050 |
Why?
|
| Carotid Artery, Internal | 1 | 2006 | 438 | 0.050 |
Why?
|
| Hyperglycemia | 2 | 2010 | 1380 | 0.050 |
Why?
|
| Learning | 1 | 2013 | 1733 | 0.050 |
Why?
|
| Diabetic Foot | 1 | 2007 | 381 | 0.050 |
Why?
|
| Audiovisual Aids | 1 | 2024 | 99 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2008 | 749 | 0.050 |
Why?
|
| Cholesterol | 3 | 2012 | 2925 | 0.050 |
Why?
|
| Liver Cirrhosis, Biliary | 2 | 2005 | 105 | 0.050 |
Why?
|
| Polymers | 1 | 2010 | 1620 | 0.050 |
Why?
|
| Mediastinum | 1 | 2004 | 265 | 0.050 |
Why?
|
| Educational Status | 4 | 2016 | 2512 | 0.050 |
Why?
|
| Cystatin C | 1 | 2024 | 270 | 0.050 |
Why?
|
| Clostridium Infections | 1 | 2009 | 557 | 0.050 |
Why?
|
| Sleep Deprivation | 1 | 2009 | 840 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 2 | 2023 | 926 | 0.050 |
Why?
|
| Space Simulation | 1 | 2022 | 9 | 0.050 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2006 | 355 | 0.050 |
Why?
|
| Isoenzymes | 3 | 2003 | 1690 | 0.050 |
Why?
|
| Vitamin A | 3 | 1996 | 613 | 0.050 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2022 | 162 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2012 | 5120 | 0.050 |
Why?
|
| User-Computer Interface | 2 | 2019 | 1402 | 0.050 |
Why?
|
| Uncertainty | 1 | 2007 | 754 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2023 | 398 | 0.050 |
Why?
|
| Infection Control | 1 | 2009 | 983 | 0.050 |
Why?
|
| Uremia | 1 | 2003 | 201 | 0.050 |
Why?
|
| Lung | 4 | 2024 | 9989 | 0.050 |
Why?
|
| Myocytes, Cardiac | 2 | 2008 | 1656 | 0.050 |
Why?
|
| Parturition | 2 | 2018 | 445 | 0.050 |
Why?
|
| Physical Examination | 1 | 2008 | 1244 | 0.050 |
Why?
|
| Anus Neoplasms | 2 | 1996 | 329 | 0.050 |
Why?
|
| Africa | 2 | 2015 | 707 | 0.050 |
Why?
|
| Colonoscopy | 2 | 2021 | 1387 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 3 | 2008 | 1628 | 0.050 |
Why?
|
| Reoperation | 5 | 2010 | 4292 | 0.050 |
Why?
|
| Mothers | 4 | 2006 | 2186 | 0.050 |
Why?
|
| Observer Variation | 2 | 2020 | 2596 | 0.050 |
Why?
|
| Organizational Case Studies | 2 | 2014 | 301 | 0.050 |
Why?
|
| Social Support | 1 | 2011 | 2145 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2010 | 1132 | 0.050 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 1405 | 0.050 |
Why?
|
| Penile Erection | 2 | 2012 | 100 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 1689 | 0.050 |
Why?
|
| Creatine Kinase, MB Form | 3 | 2008 | 211 | 0.050 |
Why?
|
| Cachexia | 1 | 2023 | 198 | 0.050 |
Why?
|
| HIV Infections | 4 | 2015 | 17159 | 0.050 |
Why?
|
| Standard of Care | 2 | 2017 | 552 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 1494 | 0.050 |
Why?
|
| Tenascin | 1 | 2001 | 62 | 0.050 |
Why?
|
| Stomach Diseases | 1 | 2002 | 133 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7400 | 0.050 |
Why?
|
| Perineum | 2 | 2014 | 209 | 0.050 |
Why?
|
| Evidence-Based Nursing | 1 | 2020 | 13 | 0.050 |
Why?
|
| Safety | 3 | 2014 | 1149 | 0.050 |
Why?
|
| Drug Administration Schedule | 5 | 2012 | 4900 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 4875 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2006 | 882 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 1109 | 0.050 |
Why?
|
| Cost of Illness | 2 | 2023 | 1940 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2011 | 2628 | 0.050 |
Why?
|
| Utah | 2 | 2016 | 131 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 822 | 0.050 |
Why?
|
| Ablation Techniques | 1 | 2023 | 249 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2008 | 1805 | 0.050 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 537 | 0.050 |
Why?
|
| North America | 2 | 2018 | 1282 | 0.040 |
Why?
|
| California | 1 | 2024 | 1416 | 0.040 |
Why?
|
| Environment Design | 1 | 2022 | 173 | 0.040 |
Why?
|
| Cholesterol, HDL | 2 | 2006 | 1817 | 0.040 |
Why?
|
| Disease Management | 2 | 2024 | 2508 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2005 | 638 | 0.040 |
Why?
|
| Anti-HIV Agents | 2 | 2010 | 4492 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 4044 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2023 | 460 | 0.040 |
Why?
|
| Trimetrexate | 1 | 1999 | 15 | 0.040 |
Why?
|
| American Cancer Society | 1 | 2019 | 62 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 988 | 0.040 |
Why?
|
| Cholesterol, LDL | 3 | 2006 | 2422 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 1098 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2010 | 1996 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2010 | 1290 | 0.040 |
Why?
|
| Disulfiram | 1 | 2020 | 63 | 0.040 |
Why?
|
| Topotecan | 1 | 2000 | 132 | 0.040 |
Why?
|
| Germ Cells | 1 | 2023 | 635 | 0.040 |
Why?
|
| Smoke Inhalation Injury | 1 | 2019 | 47 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2005 | 1521 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2668 | 0.040 |
Why?
|
| Urination Disorders | 2 | 2011 | 241 | 0.040 |
Why?
|
| Needs Assessment | 2 | 2018 | 1137 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2023 | 610 | 0.040 |
Why?
|
| Harringtonines | 1 | 1999 | 8 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2024 | 582 | 0.040 |
Why?
|
| Serum Albumin | 2 | 2016 | 674 | 0.040 |
Why?
|
| Albumins | 1 | 2022 | 577 | 0.040 |
Why?
|
| Birth Certificates | 1 | 2019 | 70 | 0.040 |
Why?
|
| Cholinergic Antagonists | 1 | 2020 | 164 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2007 | 1060 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2014 | 1577 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 1925 | 0.040 |
Why?
|
| Scotland | 1 | 2019 | 144 | 0.040 |
Why?
|
| Myocardial Contraction | 4 | 2010 | 1516 | 0.040 |
Why?
|
| Gait | 1 | 2024 | 812 | 0.040 |
Why?
|
| Language | 2 | 2024 | 1532 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 2002 | 377 | 0.040 |
Why?
|
| Technology | 1 | 2021 | 292 | 0.040 |
Why?
|
| C-Reactive Protein | 4 | 2012 | 3822 | 0.040 |
Why?
|
| Birth Weight | 2 | 2023 | 2094 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2002 | 386 | 0.040 |
Why?
|
| Stomach Neoplasms | 2 | 1999 | 1423 | 0.040 |
Why?
|
| Gentamicins | 1 | 2019 | 252 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 643 | 0.040 |
Why?
|
| Fresh Water | 1 | 1998 | 82 | 0.040 |
Why?
|
| Iatrogenic Disease | 2 | 1992 | 538 | 0.040 |
Why?
|
| Philosophy, Medical | 1 | 1998 | 79 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2023 | 789 | 0.040 |
Why?
|
| Health Policy | 1 | 2011 | 2678 | 0.040 |
Why?
|
| Acinetobacter baumannii | 1 | 2019 | 115 | 0.040 |
Why?
|
| Histological Techniques | 1 | 2019 | 194 | 0.040 |
Why?
|
| Minocycline | 1 | 2019 | 168 | 0.040 |
Why?
|
| Obesity | 4 | 2022 | 12915 | 0.040 |
Why?
|
| gamma-Globulins | 1 | 1998 | 123 | 0.040 |
Why?
|
| Clavicle | 1 | 2020 | 224 | 0.040 |
Why?
|
| Alginates | 1 | 2019 | 247 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2020 | 391 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 383 | 0.040 |
Why?
|
| Rural Population | 4 | 2017 | 2267 | 0.040 |
Why?
|
| Primary Nursing | 1 | 2017 | 10 | 0.040 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2019 | 121 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2017 | 2656 | 0.040 |
Why?
|
| Men's Health | 1 | 2018 | 70 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2011 | 2755 | 0.040 |
Why?
|
| Motivation | 2 | 2022 | 1990 | 0.040 |
Why?
|
| Hydroxyurea | 1 | 1999 | 283 | 0.040 |
Why?
|
| Mental Health Services | 2 | 2019 | 1716 | 0.040 |
Why?
|
| Jaundice | 1 | 1998 | 97 | 0.040 |
Why?
|
| Intestinal Neoplasms | 2 | 2010 | 311 | 0.040 |
Why?
|
| Respiration | 1 | 2024 | 1648 | 0.040 |
Why?
|
| Aging | 1 | 2016 | 8641 | 0.040 |
Why?
|
| Models, Economic | 2 | 2012 | 719 | 0.040 |
Why?
|
| Walking | 1 | 2024 | 1190 | 0.040 |
Why?
|
| Scleroderma, Systemic | 1 | 2001 | 344 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 2 | 2010 | 187 | 0.040 |
Why?
|
| Organizational Innovation | 2 | 2011 | 536 | 0.040 |
Why?
|
| Creatine Kinase | 3 | 2006 | 691 | 0.040 |
Why?
|
| Equipment Design | 2 | 2019 | 3520 | 0.040 |
Why?
|
| Poisons | 1 | 1997 | 38 | 0.040 |
Why?
|
| Subacute Care | 1 | 2019 | 177 | 0.040 |
Why?
|
| Myoglobin | 2 | 2008 | 159 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2008 | 6375 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 998 | 0.030 |
Why?
|
| Eye Color | 1 | 1996 | 36 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 2002 | 1155 | 0.030 |
Why?
|
| Calcinosis | 1 | 2005 | 1478 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2004 | 850 | 0.030 |
Why?
|
| Shock, Hemorrhagic | 1 | 2018 | 224 | 0.030 |
Why?
|
| Mexico | 1 | 2019 | 760 | 0.030 |
Why?
|
| Government Agencies | 1 | 2017 | 161 | 0.030 |
Why?
|
| Inappropriate Prescribing | 1 | 2019 | 209 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 1426 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 422 | 0.030 |
Why?
|
| Vancomycin | 1 | 2019 | 503 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2001 | 1201 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2002 | 1470 | 0.030 |
Why?
|
| Postnatal Care | 1 | 2018 | 260 | 0.030 |
Why?
|
| Family Planning Services | 1 | 2019 | 265 | 0.030 |
Why?
|
| Skin | 1 | 2010 | 4468 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2017 | 217 | 0.030 |
Why?
|
| Drug Therapy | 1 | 1999 | 504 | 0.030 |
Why?
|
| Spouses | 1 | 2018 | 279 | 0.030 |
Why?
|
| Genes, ras | 1 | 1999 | 654 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4440 | 0.030 |
Why?
|
| Vermont | 1 | 2016 | 83 | 0.030 |
Why?
|
| Acute Disease | 2 | 2020 | 7268 | 0.030 |
Why?
|
| Menogaril | 1 | 1995 | 4 | 0.030 |
Why?
|
| Oceania | 1 | 2015 | 17 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6457 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2002 | 819 | 0.030 |
Why?
|
| Ethanol | 1 | 2022 | 1323 | 0.030 |
Why?
|
| Cuba | 1 | 2015 | 48 | 0.030 |
Why?
|
| Self-Assessment | 1 | 2018 | 393 | 0.030 |
Why?
|
| Self Care | 1 | 2021 | 793 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1252 | 0.030 |
Why?
|
| Haiti | 1 | 2017 | 550 | 0.030 |
Why?
|
| Life Tables | 1 | 1996 | 365 | 0.030 |
Why?
|
| Americas | 1 | 2015 | 111 | 0.030 |
Why?
|
| Moldova | 1 | 2015 | 14 | 0.030 |
Why?
|
| Ultrasonography | 5 | 2010 | 5960 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 978 | 0.030 |
Why?
|
| Costa Rica | 1 | 2015 | 177 | 0.030 |
Why?
|
| Laboratories, Hospital | 1 | 2017 | 193 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2018 | 321 | 0.030 |
Why?
|
| Bleomycin | 1 | 1996 | 496 | 0.030 |
Why?
|
| Artifacts | 1 | 2024 | 1893 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 1998 | 435 | 0.030 |
Why?
|
| Frail Elderly | 1 | 2020 | 747 | 0.030 |
Why?
|
| Pain | 2 | 2023 | 5066 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 2 | 2002 | 747 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2019 | 1572 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 1155 | 0.030 |
Why?
|
| Vascular Patency | 2 | 2008 | 901 | 0.030 |
Why?
|
| Michigan | 1 | 2016 | 342 | 0.030 |
Why?
|
| Death | 1 | 2020 | 678 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2022 | 1266 | 0.030 |
Why?
|
| Oligonucleotides | 2 | 2008 | 588 | 0.030 |
Why?
|
| Community Health Services | 1 | 2000 | 654 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2016 | 222 | 0.030 |
Why?
|
| Fetal Death | 1 | 2016 | 434 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 2017 | 300 | 0.030 |
Why?
|
| Radiotherapy Dosage | 2 | 2016 | 2897 | 0.030 |
Why?
|
| Chile | 1 | 2015 | 254 | 0.030 |
Why?
|
| Women's Health | 3 | 2009 | 2057 | 0.030 |
Why?
|
| Wound Healing | 2 | 2019 | 2786 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 516 | 0.030 |
Why?
|
| Cocaine | 1 | 2020 | 961 | 0.030 |
Why?
|
| Health Personnel | 2 | 2023 | 3310 | 0.030 |
Why?
|
| Systems Integration | 1 | 2016 | 426 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2018 | 475 | 0.030 |
Why?
|
| Time | 1 | 2016 | 545 | 0.030 |
Why?
|
| China | 2 | 2015 | 2340 | 0.030 |
Why?
|
| Obstetrics | 2 | 2013 | 668 | 0.030 |
Why?
|
| Direct Service Costs | 1 | 2014 | 60 | 0.030 |
Why?
|
| Ribavirin | 1 | 1996 | 396 | 0.030 |
Why?
|
| Hydrogels | 1 | 2019 | 725 | 0.030 |
Why?
|
| Xerophthalmia | 1 | 1993 | 12 | 0.030 |
Why?
|
| Nursing Records | 1 | 2013 | 30 | 0.030 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2014 | 59 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 848 | 0.030 |
Why?
|
| El Salvador | 1 | 2013 | 34 | 0.030 |
Why?
|
| Vitamin A Deficiency | 1 | 1994 | 88 | 0.030 |
Why?
|
| Exercise | 2 | 2020 | 5783 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2061 | 0.030 |
Why?
|
| Osteosarcoma | 2 | 1996 | 898 | 0.030 |
Why?
|
| Vital Statistics | 1 | 2013 | 31 | 0.030 |
Why?
|
| Nursing Informatics | 1 | 2013 | 46 | 0.030 |
Why?
|
| Interferon-beta | 1 | 1995 | 345 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 1952 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2023 | 2091 | 0.030 |
Why?
|
| Biopsy | 2 | 2019 | 6775 | 0.030 |
Why?
|
| Colon | 1 | 2021 | 1788 | 0.030 |
Why?
|
| Graft Rejection | 2 | 2010 | 4423 | 0.030 |
Why?
|
| Patient Preference | 1 | 2020 | 921 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2015 | 555 | 0.030 |
Why?
|
| Feedback, Psychological | 1 | 2012 | 95 | 0.030 |
Why?
|
| Disease Progression | 4 | 2006 | 13505 | 0.030 |
Why?
|
| Myocardium | 2 | 2012 | 4688 | 0.030 |
Why?
|
| Information Systems | 1 | 2014 | 398 | 0.030 |
Why?
|
| France | 1 | 2013 | 511 | 0.030 |
Why?
|
| Adenoma, Islet Cell | 1 | 1992 | 72 | 0.030 |
Why?
|
| Constriction | 1 | 2012 | 171 | 0.030 |
Why?
|
| Curriculum | 2 | 2017 | 3722 | 0.020 |
Why?
|
| Reimbursement, Incentive | 1 | 2017 | 543 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 1275 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 2711 | 0.020 |
Why?
|
| Live Birth | 1 | 2015 | 512 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2017 | 909 | 0.020 |
Why?
|
| Acetazolamide | 1 | 1992 | 97 | 0.020 |
Why?
|
| Perphenazine | 1 | 2011 | 33 | 0.020 |
Why?
|
| Decision Making | 2 | 2016 | 3924 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2017 | 901 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2019 | 1462 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 10757 | 0.020 |
Why?
|
| Societies, Medical | 2 | 2016 | 3903 | 0.020 |
Why?
|
| Hospital Departments | 1 | 2011 | 136 | 0.020 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2011 | 69 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 10829 | 0.020 |
Why?
|
| Lipids | 1 | 2022 | 3336 | 0.020 |
Why?
|
| Exercise Test | 2 | 2012 | 2125 | 0.020 |
Why?
|
| Malignant Hyperthermia | 1 | 2011 | 71 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2019 | 1032 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 3451 | 0.020 |
Why?
|
| Economics, Hospital | 1 | 1993 | 212 | 0.020 |
Why?
|
| Affect | 1 | 1999 | 1479 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2005 | 2853 | 0.020 |
Why?
|
| Nursing Methodology Research | 1 | 2010 | 64 | 0.020 |
Why?
|
| Ownership | 1 | 2013 | 339 | 0.020 |
Why?
|
| Dibenzothiazepines | 1 | 2011 | 102 | 0.020 |
Why?
|
| Embolism, Air | 1 | 2011 | 110 | 0.020 |
Why?
|
| Personality | 1 | 2014 | 552 | 0.020 |
Why?
|
| Organizational Culture | 1 | 2014 | 506 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1995 | 625 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2012 | 295 | 0.020 |
Why?
|
| Animals | 7 | 2023 | 167940 | 0.020 |
Why?
|
| Awareness | 1 | 2015 | 644 | 0.020 |
Why?
|
| Reference Values | 2 | 2009 | 4920 | 0.020 |
Why?
|
| Role Playing | 1 | 2010 | 22 | 0.020 |
Why?
|
| Fat Necrosis | 1 | 2010 | 60 | 0.020 |
Why?
|
| Mitomycin | 2 | 2005 | 262 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 2220 | 0.020 |
Why?
|
| Africa, Northern | 1 | 2010 | 86 | 0.020 |
Why?
|
| Coronary Artery Disease | 2 | 2012 | 6661 | 0.020 |
Why?
|
| Photography | 1 | 2013 | 530 | 0.020 |
Why?
|
| Heart Transplantation | 2 | 2002 | 3217 | 0.020 |
Why?
|
| Liability, Legal | 1 | 1992 | 210 | 0.020 |
Why?
|
| Epigastric Arteries | 1 | 2010 | 92 | 0.020 |
Why?
|
| Urban Population | 2 | 2009 | 2021 | 0.020 |
Why?
|
| Transferrin | 1 | 2011 | 284 | 0.020 |
Why?
|
| Social Class | 2 | 2016 | 2005 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 3 | 1999 | 3763 | 0.020 |
Why?
|
| Endoscopy | 1 | 2020 | 1841 | 0.020 |
Why?
|
| Software Design | 1 | 1990 | 171 | 0.020 |
Why?
|
| Housekeeping, Hospital | 1 | 2009 | 17 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 3106 | 0.020 |
Why?
|
| Utilization Review | 1 | 2011 | 383 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2010 | 12412 | 0.020 |
Why?
|
| Middle East | 1 | 2010 | 230 | 0.020 |
Why?
|
| New Zealand | 1 | 2010 | 355 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 680 | 0.020 |
Why?
|
| Swine | 1 | 2019 | 5902 | 0.020 |
Why?
|
| Ligation | 1 | 2010 | 448 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2016 | 935 | 0.020 |
Why?
|
| Hernia, Abdominal | 1 | 2010 | 56 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2011 | 389 | 0.020 |
Why?
|
| Mental Disorders | 2 | 1999 | 6797 | 0.020 |
Why?
|
| Urinary Catheterization | 1 | 2010 | 200 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 817 | 0.020 |
Why?
|
| Traction | 1 | 2009 | 106 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2013 | 625 | 0.020 |
Why?
|
| Specialty Boards | 1 | 2011 | 235 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2010 | 373 | 0.020 |
Why?
|
| Radiography | 2 | 2011 | 6965 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2002 | 3804 | 0.020 |
Why?
|
| Students, Medical | 2 | 2014 | 1926 | 0.020 |
Why?
|
| Switzerland | 1 | 2009 | 323 | 0.020 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 93 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1992 | 338 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 1189 | 0.020 |
Why?
|
| Diastole | 2 | 2002 | 788 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1675 | 0.020 |
Why?
|
| Vocal Cord Paralysis | 1 | 2012 | 272 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2010 | 1154 | 0.020 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2010 | 103 | 0.020 |
Why?
|
| Latin America | 1 | 2010 | 405 | 0.020 |
Why?
|
| Tissue Expansion Devices | 1 | 2010 | 156 | 0.020 |
Why?
|
| ROC Curve | 2 | 2011 | 3568 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2011 | 429 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2005 | 853 | 0.020 |
Why?
|
| Poverty Areas | 1 | 2010 | 264 | 0.020 |
Why?
|
| Group Processes | 1 | 2010 | 226 | 0.020 |
Why?
|
| Europe | 1 | 2015 | 3433 | 0.020 |
Why?
|
| Breast | 1 | 2017 | 1980 | 0.020 |
Why?
|
| Age of Onset | 2 | 2011 | 3302 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2009 | 249 | 0.020 |
Why?
|
| Apgar Score | 1 | 2008 | 126 | 0.020 |
Why?
|
| Anxiety | 1 | 2023 | 4532 | 0.020 |
Why?
|
| Program Development | 1 | 2014 | 1297 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1256 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 258 | 0.020 |
Why?
|
| Disclosure | 1 | 2014 | 738 | 0.020 |
Why?
|
| Licensure, Medical | 1 | 2008 | 68 | 0.020 |
Why?
|
| Dissection | 1 | 2009 | 298 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2015 | 1349 | 0.020 |
Why?
|
| Health Plan Implementation | 1 | 2011 | 335 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 923 | 0.020 |
Why?
|
| Marriage | 1 | 2009 | 351 | 0.020 |
Why?
|
| Exercise Therapy | 1 | 2014 | 920 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2007 | 60 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2011 | 351 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2010 | 743 | 0.020 |
Why?
|
| Developed Countries | 1 | 2010 | 443 | 0.020 |
Why?
|
| Policy Making | 1 | 2011 | 539 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2017 | 1915 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2012 | 651 | 0.020 |
Why?
|
| Mass Media | 1 | 2010 | 300 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2014 | 1500 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2007 | 91 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 1109 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1995 | 1738 | 0.020 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2009 | 291 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1995 | 951 | 0.020 |
Why?
|
| Home Care Services | 1 | 2013 | 653 | 0.020 |
Why?
|
| Hormones | 1 | 2011 | 867 | 0.020 |
Why?
|
| Negotiating | 1 | 2008 | 148 | 0.020 |
Why?
|
| Taiwan | 2 | 1998 | 503 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2007 | 200 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2010 | 983 | 0.020 |
Why?
|
| Gestational Age | 1 | 2015 | 3564 | 0.020 |
Why?
|
| Seizures | 1 | 2019 | 2916 | 0.020 |
Why?
|
| Wisconsin | 1 | 2006 | 122 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2012 | 903 | 0.020 |
Why?
|
| Physician Assistants | 1 | 2009 | 188 | 0.020 |
Why?
|
| Scientific Misconduct | 1 | 2007 | 74 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 1731 | 0.020 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 192 | 0.020 |
Why?
|
| Australia | 1 | 2010 | 1288 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2008 | 4169 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1534 | 0.020 |
Why?
|
| Recurrence | 2 | 2010 | 8487 | 0.020 |
Why?
|
| Breast Implants | 1 | 2010 | 411 | 0.020 |
Why?
|
| Hospitals, Private | 1 | 2006 | 63 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2010 | 699 | 0.020 |
Why?
|
| Counseling | 1 | 2014 | 1550 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 1612 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 751 | 0.020 |
Why?
|
| Models, Educational | 1 | 2008 | 372 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 613 | 0.020 |
Why?
|
| Pericardium | 1 | 2010 | 675 | 0.020 |
Why?
|
| Urologic Surgical Procedures | 1 | 2008 | 310 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2010 | 708 | 0.020 |
Why?
|
| Focus Groups | 1 | 2010 | 1372 | 0.020 |
Why?
|
| Penicillamine | 1 | 2005 | 60 | 0.020 |
Why?
|
| Body Temperature | 1 | 2008 | 777 | 0.020 |
Why?
|
| Accreditation | 1 | 2008 | 477 | 0.020 |
Why?
|
| Social Environment | 1 | 2010 | 1020 | 0.020 |
Why?
|
| Memory | 1 | 2014 | 2179 | 0.020 |
Why?
|
| Anesthesia | 1 | 2016 | 1584 | 0.020 |
Why?
|
| Heart Rate | 2 | 2008 | 4169 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 1206 | 0.010 |
Why?
|
| Catheterization, Central Venous | 1 | 2009 | 526 | 0.010 |
Why?
|
| Device Removal | 1 | 2009 | 634 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2007 | 449 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 2008 | 585 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 4024 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 2006 | 513 | 0.010 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2004 | 62 | 0.010 |
Why?
|
| Catheterization | 1 | 2009 | 1432 | 0.010 |
Why?
|
| Health Literacy | 1 | 2009 | 440 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 2532 | 0.010 |
Why?
|
| Tissue Scaffolds | 1 | 2010 | 927 | 0.010 |
Why?
|
| Sudan | 2 | 1994 | 86 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2011 | 753 | 0.010 |
Why?
|
| Mice | 4 | 2009 | 81216 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 1998 | 4404 | 0.010 |
Why?
|
| Geography | 1 | 2006 | 661 | 0.010 |
Why?
|
| Gynecology | 1 | 2009 | 534 | 0.010 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 488 | 0.010 |
Why?
|
| Hypopituitarism | 1 | 2005 | 248 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 1388 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 2127 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 1705 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2006 | 641 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1995 | 2297 | 0.010 |
Why?
|
| Heart Block | 1 | 2004 | 392 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2004 | 384 | 0.010 |
Why?
|
| Japan | 1 | 2007 | 1369 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2007 | 739 | 0.010 |
Why?
|
| Mental Recall | 1 | 2009 | 1205 | 0.010 |
Why?
|
| Floxuridine | 1 | 2002 | 43 | 0.010 |
Why?
|
| Hospital Records | 2 | 1993 | 93 | 0.010 |
Why?
|
| Fatigue | 1 | 2009 | 1544 | 0.010 |
Why?
|
| Hypotension | 1 | 2008 | 883 | 0.010 |
Why?
|
| Medicine | 1 | 2010 | 943 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 1633 | 0.010 |
Why?
|
| Colorado | 1 | 2002 | 164 | 0.010 |
Why?
|
| Peritoneal Dialysis | 1 | 2003 | 157 | 0.010 |
Why?
|
| Low Back Pain | 1 | 2010 | 979 | 0.010 |
Why?
|
| Tachycardia | 1 | 2004 | 603 | 0.010 |
Why?
|
| International Classification of Diseases | 1 | 2007 | 884 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2002 | 221 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2001 | 43 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3421 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2008 | 1343 | 0.010 |
Why?
|
| Hyperparathyroidism | 1 | 2003 | 339 | 0.010 |
Why?
|
| Thorax | 1 | 2004 | 553 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1999 | 5131 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2007 | 1548 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 2002 | 230 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2010 | 2314 | 0.010 |
Why?
|
| Anthropometry | 1 | 2005 | 1348 | 0.010 |
Why?
|
| Anemia | 1 | 2010 | 1511 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2006 | 1108 | 0.010 |
Why?
|
| Cisplatin | 2 | 1996 | 1642 | 0.010 |
Why?
|
| Patient Transfer | 1 | 2007 | 778 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1655 | 0.010 |
Why?
|
| Graft Survival | 1 | 2010 | 3793 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 1121 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2010 | 3514 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 1544 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3587 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 5797 | 0.010 |
Why?
|
| Agranulocytosis | 1 | 1999 | 99 | 0.010 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2008 | 1066 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2001 | 750 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 2004 | 1016 | 0.010 |
Why?
|
| Placebos | 1 | 2003 | 1672 | 0.010 |
Why?
|
| Body Height | 1 | 2005 | 1570 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2002 | 368 | 0.010 |
Why?
|
| Thrombin | 1 | 2001 | 593 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 12959 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1697 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2001 | 459 | 0.010 |
Why?
|
| Connecticut | 1 | 1999 | 364 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2010 | 3293 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 2476 | 0.010 |
Why?
|
| Electrocardiography | 2 | 2004 | 6413 | 0.010 |
Why?
|
| Life Style | 1 | 2009 | 3888 | 0.010 |
Why?
|
| Antibodies | 1 | 2006 | 2424 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 3061 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2006 | 3618 | 0.010 |
Why?
|
| Weight Loss | 1 | 2009 | 2683 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 1999 | 412 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2007 | 1401 | 0.010 |
Why?
|
| Codon | 1 | 1999 | 602 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 1001 | 0.010 |
Why?
|
| Urbanization | 1 | 1997 | 100 | 0.010 |
Why?
|
| Leucovorin | 1 | 1999 | 639 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 12281 | 0.010 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1996 | 94 | 0.010 |
Why?
|
| Total Lung Capacity | 1 | 1996 | 149 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1996 | 306 | 0.010 |
Why?
|
| Stomatitis | 1 | 1999 | 271 | 0.010 |
Why?
|
| Overweight | 1 | 2007 | 2421 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1996 | 412 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1996 | 415 | 0.010 |
Why?
|
| Nutritional Status | 2 | 1994 | 1606 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 11064 | 0.010 |
Why?
|
| Fever | 1 | 2002 | 1618 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 23695 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 29950 | 0.010 |
Why?
|
| Medical Indigency | 1 | 1993 | 63 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2003 | 1802 | 0.010 |
Why?
|
| Sleep | 1 | 2009 | 4746 | 0.010 |
Why?
|
| Financial Management, Hospital | 1 | 1993 | 69 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2006 | 2843 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14396 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7072 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1993 | 296 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2007 | 3606 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1996 | 1810 | 0.010 |
Why?
|
| Remission Induction | 1 | 1996 | 2394 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2001 | 4091 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 4546 | 0.010 |
Why?
|
| Cough | 1 | 1994 | 595 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 1991 | 175 | 0.010 |
Why?
|
| Methotrexate | 1 | 1996 | 1717 | 0.010 |
Why?
|
| Neutropenia | 1 | 1995 | 884 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1996 | 1505 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2002 | 3822 | 0.010 |
Why?
|
| Antirheumatic Agents | 1 | 1999 | 1374 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6131 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18134 | 0.000 |
Why?
|
| Diarrhea | 1 | 1994 | 1341 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2001 | 12762 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2001 | 18968 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2001 | 23363 | 0.000 |
Why?
|